DrugPatentWatch Database Preview
Otsuka Pharm Co Ltd Company Profile
What is the competitive landscape for OTSUKA PHARM CO LTD, and when can generic versions of OTSUKA PHARM CO LTD drugs launch?
OTSUKA PHARM CO LTD has five approved drugs.
There are forty-seven US patents protecting OTSUKA PHARM CO LTD drugs.
Summary for Otsuka Pharm Co Ltd
| US Patents: | 47 |
| Tradenames: | 5 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Otsuka Pharm Co Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-003 | Sep 29, 2014 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Otsuka Pharm Co Ltd | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-003 | Nov 13, 2017 | RX | Yes | No | 9,089,567 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Otsuka Pharm Co Ltd | REXULTI | brexpiprazole | TABLET;ORAL | 205422-002 | Jul 10, 2015 | RX | Yes | No | 7,888,362 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-001 | Feb 28, 2013 | RX | Yes | No | 8,338,428 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Otsuka Pharm Co Ltd | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-001 | Nov 13, 2017 | RX | Yes | No | 8,718,193 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Otsuka Pharm Co Ltd | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-002 | Nov 13, 2017 | RX | Yes | Yes | 9,433,371 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-002 | Feb 28, 2013 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Otsuka Pharm Co Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-004 | Sep 29, 2014 | 5,006,528*PED | ➤ Try a Free Trial |
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-001 | Feb 28, 2013 | 5,006,528*PED | ➤ Try a Free Trial |
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-002 | Feb 28, 2013 | 5,006,528*PED | ➤ Try a Free Trial |
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-003 | Sep 29, 2014 | 5,006,528*PED | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Non-Orange Book US Patents for Otsuka Pharm Co Ltd
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 9,006,248 | 5-HT.sub.1A receptor subtype agonist | ➤ Try a Free Trial |
| 8,802,183 | Communication system with enhanced partial power source and method of manufacturing same | ➤ Try a Free Trial |
| 9,083,589 | Active signal processing personal health signal receivers | ➤ Try a Free Trial |
| 9,387,207 | 5-HT1A receptor subtype agonist | ➤ Try a Free Trial |
| 9,439,566 | Re-wearable wireless device | ➤ Try a Free Trial |
| 8,703,772 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof | ➤ Try a Free Trial |
| 9,480,686 | Piperazine-substituted benzothiophenes for treatment of mental disorders | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Otsuka Pharm Co Ltd Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Australia | 2004285448 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2010075115 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2008063626 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2008101107 | ➤ Try a Free Trial |
| Israel | 230497 | ➤ Try a Free Trial |
| Poland | 393601 | ➤ Try a Free Trial |
| Australia | 2004264886 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Otsuka Pharm Co Ltd Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2009 00031 | Denmark | ➤ Try a Free Trial | |
| C/GB09/037 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: TOLVAPTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/09/539/001 20090803; UK EU/1/09/539/002 20090803; UK EU/1/09/539/003 20090803; UK EU/1/09/539/004 20090803 |
| /2014 | Austria | ➤ Try a Free Trial | PRODUCT NAME: ARIPIPRAZOL; REGISTRATION NO/DATE: EU/1/13/882 (MITTEILUNG) 20131119 |
| 9 5013-2014 | Slovakia | ➤ Try a Free Trial | PRODUCT NAME: ARIPIPRAZOL; REGISTRATION NO/DATE: EU/1/13/882/001 - EU/1/13/882/004 20131119 |
| 0408 | Netherlands | ➤ Try a Free Trial | 300408, 20101018, EXPIRES: 20151017 |
| 2014 00026 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: ARIPIPRAZOL; REG. NO/DATE: EU/1/13/882/001-004 20131115 |
| 0669 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: ARIPIPRAZOLE; REGISTRATION NO/DATE: EU/1/13/882 20131115 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
